Alessandro Noseda - 02 Aug 2021 Form 4 Insider Report for REGENERX BIOPHARMACEUTICALS INC

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for Alessandro Noseda pursuant to Power of Attorney previously filed.
Issuer symbol
RGRX on OTC
Transactions as of
02 Aug 2021
Net transactions value
$0
Form type
4
Filing time
04 Aug 2021, 16:06:28 UTC
Next filing
19 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGRX Stock Option (right to buy) Award $0 +240,000 $0.000000 240,000 02 Aug 2021 Common Stock 240,000 $0.2800 Direct F3
holding RGRX Stock Option (right to buy) 200,000 02 Aug 2021 Common Stock 200,000 $0.2100 Direct F1
holding RGRX Stock Option (right to buy) 200,000 02 Aug 2021 Common Stock 200,000 $0.3000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
F2 50,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.
F3 60,000 shares vest on each of 8/2/21, 8/2/22, 8/2/23 and 8/2/24.